Noradrenergic regulation of inflammatory gene expression in brain

Neurochemistry International

Volumn 41, Issue 5, 2002, Pages 357-365

  Feinstein, Douglas L ^a,c   Heneka, Michael T ^b   Gavrilyuk, Vitaliy ^a   Dello Russo, Cinzia ^a   Weinberg, Guy ^a   Galea, Elena ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c MC 519 ^*  (United States)

Author keywords

Alzheimer's disease; Astrocyte; Interleukin; Microglia; Multiple sclerosis; Nitric oxide; Noradrenaline

Indexed keywords

AMYLOID BETA PROTEIN; NORADRENALIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BLOOD BRAIN BARRIER; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; NONHUMAN; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BRAIN LEVEL; DENERVATION; GENETICS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PATHOLOGY; PHYSIOLOGY; REVIEW; SENILE PLAQUE;

ANIMAL; BRAIN CHEMISTRY; DENERVATION; HUMAN; IMMUNOSUPPRESSION; INFLAMMATION; NOREPINEPHRINE; SENILE PLAQUES; ANIMALS; HUMANS;

EID: 0035993240     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00049-9     Document Type: Article

References (121)

1. Changes in the brain catecholamines in patients with dementia of Alzheimer type
2. Inflammation and Alzheimer's disease
3. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer's disease and some other degenerative neurological disorders
4. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF kappa B
5. Chemokines and viral diseases of the central nervous system
6. Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression
7. Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells
8. A beta-adrenergic agonist modulates DR alpha gene transcription via enhanced cAMP levels in a glioblastoma multiforme line
9. Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system
10. Immunological aspects of microglia: Relevance to Alzheimer's disease
11. Adenosine-induced immunosuppression: The role of the adenosine receptor - Adenylate cyclase interaction in the alteration of T-lymphocyte surface phenotype and immunoregulatory function
12. Catecholamines stimulate MHC class I, class II, and invariant chain gene expression in brain endothelium through different mechanisms
13. Cyclic AMP potentiation of cytokine-induced nitric oxide synthase activity in a murine astrocyte cell line
14. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production
15. The adhesion molecule and cytokine profile of multiple sclerosis lesions
16. The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats
17. Repression of proinflammatory cytokine and inducible nitric oxide synthase (NOS2) gene expression in activated microglia by N-acetyl-O-methyldopamine: Protein kinase A-dependent mechanism
18. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain
19. Serotonin in the regulation of brain microcirculation
20. Ultrastructural analysis of tryptophan hydroxylase immunoreactive nerve terminals in the rat cerebral cortex and hippocampus: Their associations with local blood vessels
21. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex
22. Catecholamines stimulate the IFN-gamma-induced class II MHC expression on bovine brain capillary endothelial cells
23. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
24. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors
25. Astrocytes brain, human macrophages, immunocytochemistry, macrophage, isolation, nitric oxide synthase, and spinal cord. immunocytochemical characterizatoinof the expression of the inducibale and constitutive isoforms of nitric oxide synthase in demyelinating mulitiple sclerosis lesions
26. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
27. Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis
28. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice
29. The sympathetic nerve - An integrative interface between two supersystems: The brain and the immune system
30. Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia
31. ICAM-1-coupled signaling pathways in astrocytes converge to cyclic AMP response element-binding protein phosphorylation and TNF-alpha secretion
32. Beta-adrenergic agonists exert their anti-inflammatory effects in monocytic cells through the I kappa B/NF kappa B pathway
33. Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS2 promoter activity
34. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures
35. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: An additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
36. Presenile dementia with Lewy bodies and neurofibrillary tangles
37. Histochemical characterization of a neocortical projection of the nucleus locus coeruleus in the squirrel monkey
38. Experimentally-induced neuron loss in the locus coeruleus of adult rats
39. The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: Relevance to intracerebral antigen presentation
40. Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms
41. Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes
42. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP
43. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures
44. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells
45. Prevention of autoimmune demyelination in non-human primates by a camp-specific phosphodiesterase inhibitor
46. Disease-specific patterns of locus coeruleus cell loss
47. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway
48. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
49. Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation
50. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism
51. Differential regulation of cytokine-induced major histocompatibility complex class II expression and nitric oxide release in rat microglia and astrocytes by effectors of tyrosine kinase, protein kinase C, and cAMP
52. Expression and function of inducible nitric oxide synthase in neurons
53. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase
54. Noradrenergic depletion potentiates - Amyloid induced cortical inflammation: Implications for Alzheimer's disease
55. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo
56. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer's disease
57. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells
58. Bright and dark sides of nitric oxide in ischemic brain injury
59. Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type
60. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex
61. Locus ceruleus and immunity. Part II. Suppression of experimental allergic encephalomyelitis and hypersensitivity skin reactions in rats with lesioned locus ceruleus
62. Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice
63. Brain microvessels are innervated by locus ceruleus noradrenergic neurons
64. Central catecholamine neurotoxin administration. Part 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitis
65. Cytokines and adhesion molecules in stroke and related diseases
66. Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine
67. Inflammation in the nervous system. Basic mechanisms and immunological concepts
68. Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia
69. Inducible nitric oxide synthase immunoreactivity in the Alzheimer's disease hippocampus: Association with Hirano bodies, neurofibrillary tangles, and senile plaques
70. Adhesion molecule expression and regulation on cells of the central nervous system
71. ICAM-1-induced expression of proinflammatory cytokines in astrocytes: Involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways
72. Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids
73. Electrophysiological changes accompanying DSP4 lesions of rat locus coeruleus neurons
74. The pathology of the human locus ceruleus
75. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF kappa B activation induced by various inflammatory agents
76. Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged
77. Neurodegenerative disorders and ischemic brain diseases
78. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease
79. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
80. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors
81. Partial inhibition of AT-EAE by an antibody to ICAM-1: Clinico-histological and MRI studies
82. DSP4 treatment worsens hippocampal pyramidal cell damage after transient ischemia
83. Inhibition of inducible nitric oxide synthase expression by endothelin in rat glial cells prepared from the neonatal rat brain
84. Adrenergic mediation of TNF alpha-stimulated ICAM-1 expression on human brain microvascular endothelial cells
85. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis
86. Decreased activity of locus coeruleus neurons in the rat after DSP-4 treatment
87. Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes
88. Ultrastructural evidence for combined action of noradrenaline and vasoactive intestinal polypeptide upon neurons, astrocytes, and blood vessels of the rat cerebral cortex
89. Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction
90. Beta-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia(1)
91. Interleukin 1 in the brain: Biology, pathology and therapeutic target
92. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1, but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats
93. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family
94. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors
95. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes
96. Denervation microangiopathy in senile dementia: Alzheimer type
97. Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta
98. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro
99. Association of microglia with amyloid plaques in brains of APP23 transgenic mice
100. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro
101. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide produciton and protects against the development of vascular hyporeactivity in endotoxaemia
102. Inhibition of human platelet aggregation by dihydropy
103. Glia and Alzheimer's disease
104. Amyloid-beta peptide activates cultured glia: Cytokine induction and nitric oxide release
105. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system
106. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes
107. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease
108. Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques
109. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis
110. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice
111. Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis
112. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats
113. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type
114. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
115. Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells
116. Role of transcription factor NF kappa B/Rel in induction of nitric oxide synthase
117. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide
118. [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain
119. Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules
120. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with borna disease correlate with the induction of nitric oxide synthase
121. High beta-adrenoceptor density on peripheral blood mononuclear cells in progressive multiple sclerosis: A manifestation of autonomic dysfunction?